Condition:   Juvenile Idiopathic Arthritis
Interventions:   Biological: CNTO 148 (Golimumab);   Biological: CNTO 148 (golimumab) or placebo
Sponsors:   Centocor, Inc.;   Schering-Plough (Ireland) Company
Recruiting - verified August 2011